JPRN-UMIN000011023已完成2 期
A Phase II Study of Neo-adjuvant Combination Therapy of Trastuzumab and Anastrozole for Hormone Receptor-Positive, HER2-Positive Postmenopausal Breast Cancer(WJOG7412B) - "TRAstuzumab and ANAstrozole for breast cancer" WJOG7412B/Tra-Ana study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)Active infection under treatment 2)Concurrent serious disease or condition 3)Pulmonary fibrosis or interstitial pneumonitis by chest X-ray 4)Abnormal electrocardiography findings with clinical symptoms 5)Patients with other active malignancies 6)Concurrent serious psychiatric disorder 7)Concurrent massive body cavity fluid (pleural effusion, ascites or cardiac effusion, etc)needs treatment 8)Concurrent continuous systemic treatment with steroids 9)History of serious allergic reactions 10)HBsAg or HCVAb-positive 11)Patient considered irrelevant by the attending physician for the study
研究者
相似试验
已完成
2 期
A Phase II study of neoadjuvant combination chemotherapy with TS-1, cisplatin and Paclitaxel (PCS) for resectable advanced gastric cancer.resectable advanced gastric cancerJPRN-UMIN000006674Kinki University Faculty of Medicine20
进行中（未招募）
1 期
Phase Ib/II study assessing the neo-adjuvant combination therapy of vinflunine with cisplatin followed by radical cystectomy in patients with muscle-invasive bladder cancerEUCTR2016-000081-33-DEigartis GmbH42
招募中
2 期
Phase II trial exploring combined neoadjuvant therapy with Pembrolizumab/Lenvatinib and adjuvant Pembrolizumab in patients with surgically resectable Non-Small- Cell Lung Cancer (NSCLC)2024-514821-45-00Medizinische Universitaet Innsbruck33
招募中
1 期
A phase I clinical trial on combined (neo-)adjuvant intravenous plus intracranial administration of ipilimumab and nivolumab in recurrent glioblastoma.MedDRA version: 20.0Level: PTClassification code: 10018337Term: Glioblastoma multiforme Class: 100000004864MedDRA version: 20.0Level: PTClassification code: 10018336Term: Glioblastoma Class: 100000004864glioblastomaCTIS2023-508278-26-01Z Brussel18
进行中（未招募）
1 期
Clinical trial for the evaluation of a new drug (cabozantinib) treatment given before having kidney surgery in patients with kidney cancer that is advanced or has spreadocally Advanced or Metastatic Renal Cell CarcinomaMedDRA version: 20.0Level: PTClassification code 10050513Term: Metastatic renal cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-001201-93-ESFundación ONCOSUR50